These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17697617)

  • 1. [Evaluation of the P-gp pump function on leukemic cell membrane and proper application of its reversal agents with Calcein-AM and flow cytometry].
    Lan ZJ; Tang YM; Shen HQ; Qian BQ; Ning BT; Chen YH
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):334-8. PubMed ID: 17697617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synergistic reversal effect of Chinese medicine compound FFJZ combined with cyclosporine A on multidrug resistance of leukemia K562/VCR cell line].
    Liao B; Ge RY; Chen X; Huangfu ZP; Qi Y; Song YP; Wei XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):752-5. PubMed ID: 17708797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
    van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
    Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
    Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
    Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
    Ishida Y; Shimada Y; Shimoyama M
    Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS; He L; Liu GQ
    Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
    Nygren P; Larsson R
    Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML.
    Legrand O; Simonin G; Perrot JY; Zittoun R; Marie JP
    Adv Exp Med Biol; 1999; 457():161-75. PubMed ID: 10500791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional fluo-3/AM assay on P-glycoprotein transport activity in L1210/VCR cells by confocal microscopy.
    Orlický J; Sulová Z; Dovinová I; Fiala R; Zahradníková A; Breier A
    Gen Physiol Biophys; 2004 Sep; 23(3):357-66. PubMed ID: 15638123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line.
    Zhai X; Lu J; Wang Y; Fang F; Li B; Gu W
    J Tradit Chin Med; 2014 Dec; 34(6):678-83. PubMed ID: 25618972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by a cyclosporin D analogue PSC 833].
    Dai H; Luo S; Yin A; Peng A
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):23-6. PubMed ID: 12015084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
    Fu J; Chen Z; Cen J; Ruan C
    Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P glycoprotein regulated transport of glutamate at blood brain barrier.
    Liu XD; Liu GQ
    Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.